← Eichor
Condition: Hepatic Metabolic Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatic Metabolic Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Phase 2 · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06599918Faecal Microbiota Transplantation for Liver Cirrhosis
Phase 2/Phase 3 · 1 location(s) · University of Aarhus · NCT04932577Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis
NA · 1 location(s) · Air Force Military Medical University, China · NCT07253389Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Phase 4 · 6 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04073290A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Phase N/A · 3 location(s) · Novartis Pharmaceuticals · NCT07683065Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
Phase N/A · 1 location(s) · Chongqing Medical University · NCT05974904Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation
NA · 2 location(s) · Kalliopi Anna Poulia · NCT07561138A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperit
Phase 1 · 1 location(s) · Portal Diabetes, Inc. · NCT07341373A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · 563 location(s) · Eli Lilly and Company · NCT07165028The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
Phase N/A · 1 location(s) · University of Malaya · NCT07418008Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Phase 4 · 1 location(s) · The Cleveland Clinic · NCT07058155Identification of Acute Intermittent Porphyria Modifying Genes
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT05502133Evaluation of Miricorilant on Liver Fat in Patients With MASLD
Phase 1 · 1 location(s) · Corcept Therapeutics · NCT06947304US Benchmarking Clinical Study
Phase N/A · 3 location(s) · eMyosound SAS · NCT07215715Effect of C-peptide on Hypoglycemic Counterregulation
EARLY_Phase 1 · 1 location(s) · University of Cincinnati · NCT06470295Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
Phase N/A · 1 location(s) · Izmir Bakircay University · NCT07414095Nottingham Community Liver Biomarkers Cohort
Phase N/A · 1 location(s) · University of Nottingham · NCT02037867Hepatic Lipid Metabolism-Alcohol Use Disorder
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT07191561Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD
NA · 2 location(s) · Seoul National University Hospital · NCT07192159Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06619106Fructose and Liver Diseases in Youth: Help Them FLY
NA · 1 location(s) · University of Alberta · NCT05528471Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
NA · 1 location(s) · General Hospital of Shenyang Military Region · NCT06483737Effect of Indianized Version of Mediterranean Diet vs. Low Fat Diet on Hepatic Steatosis in Overweight Children and Adol
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06768216Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07326865Affect of Melatonin on Sleep and Cognition in Cirrhosis
NA · 1 location(s) · Weill Medical College of Cornell University · NCT07046429Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
Phase 2 · 1 location(s) · Hunter Holmes Mcguire Veteran Affairs Medical Center · NCT06052176A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis
Phase 4 · 2 location(s) · Asian Institute of Gastroenterology, India · NCT06808074A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Phase 1 · 3 location(s) · GlaxoSmithKline · NCT07358546Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Phase 4 · 1 location(s) · Zhujiang Hospital · NCT06449833
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.